Inhibition of dipeptide repeat proteins
Disclosed are methods for treating neurodegenerative disorders, such as ALS and FTD, by using an effective amount of a Type I protein arginine methyltransferase (Type I PRMT) inhibitor to reduce cytotoxicity caused by the dipeptide repeat protein (DRP). 公开了用于通过使用有效量的I型蛋白质精氨酸甲基转移酶(I型PRMT)抑制剂来降低由二肽重复蛋...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Disclosed are methods for treating neurodegenerative disorders, such as ALS and FTD, by using an effective amount of a Type I protein arginine methyltransferase (Type I PRMT) inhibitor to reduce cytotoxicity caused by the dipeptide repeat protein (DRP).
公开了用于通过使用有效量的I型蛋白质精氨酸甲基转移酶(I型PRMT)抑制剂来降低由二肽重复蛋白(DRP)引起的细胞毒性以治疗神经退行性病症例如ALS和FTD的方法。 |
---|